Related Experiment Video
Updated: Feb 3, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Social Risk and Mortality: A Cohort Study in Patients With Advanced Heart Failure
Caterina Checa1, Rosa Abellana, Jose-Maria Verdú-Rotellar
1Caterina Checa, MSc, RN PhD Student, Primary Healthcare University Research Institute IDIAP-JordiGol; and Primary Healthcare Centre Dreta de l'Eixample, Barcelona; and Departament de Pediatria, Obstetricia i Ginecologia i Medicina Preventiva, Universitat Autònoma de Barcelona, Bellaterra, Spain. Rosa Abellana, PhD Statistician, Primary Healthcare University Research Institute IDIAP-JordiGol, Barcelona, Spain. Jose-Maria Verdú-Rotellar, MD, PhD Senior Researcher, Primary Healthcare University Research Institute IDIAP-JordiGol, Barcelona; Departament de Pediatria, Obstetricia i Ginecologia i Medicina Preventiva, Universitat Autònoma de Barcelona, Bellaterra; and Institut Català de la Salut, Barcelona, Spain. Anna Berenguera, PhD Senior Researcher, Primary Healthcare University Research Institute IDIAP-JordiGol, Barcelona; and Departament de Pediatria, Obstetricia i Ginecologia i Medicina Preventiva, Universitat Autònoma de Barcelona, Bellaterra, Spain. Mar Domingo, MD, PhD Senior Researcher, Primary Healthcare University Research Institute IDIAP-JordiGol; and Institut Català de la Salut, Barcelona; and Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. Esther Calero, MSc, RN PhD Student, Primary Healthcare University Research Institute IDIAP-JordiGol; and Institut Català de la Salut, Barcelona, Spain. Miguel-Angel Muñoz Pérez, MD, PhD Senior Researcher, Primary Healthcare University Research Institute IDIAP-JordiGol, Barcelona; Departament de Pediatria, Obstetricia i Ginecologia i Medicina Preventiva, Universitat Autònoma de Barcelona, Bellaterra; and Institut Català de la Salut, Barcelona, Spain.
Background:
Heart failure (HF) is a chronic condition that usually leads to death a few years after diagnosis. Although several clinical factors have been found to be related to increased mortality, less is known about the impact of social context, especially at the end stage of the disease. Knowing about social context is important to properly classify risk and provide holistic management for patients with advanced HF.
Objective:
The aim of this study was to determine the impact of social context on mortality in patients with advanced HF.
Methods:
A retrospective cohort study was conducted using data from clinical records on community-dwelling patients with HF and with New York Heart Association IV functional class living in Catalonia in northeastern Spain. Clinical data, patient dependency for basic activities of daily living, and social assessments were collected between 2010 and 2013. The primary outcome was all-cause mortality.
Results:
Data from 1148 New York Heart Association class IV patients were analyzed. Mean (SD) age was 82 (9.0) years, and 61.7% were women. The mean (SD) follow-up was 18.2 (11.9) months. Mortality occurred in 592 patients. Social risk was identified in 63.6% of the patients, and 9.3% acknowledged having social problems. In the adjusted multivariate model, being male (hazard ratio (HR), 1.82; 95% confidence interval [CI], 1.16-2.83), having high dependency on others for basic activities of daily living (HR, 2.16; 95% CI, 1.21-3.85), and presenting with a social problem (HR, 2.46; 95% CI, 1.22-4.97) were related to an increased risk of mortality.
Conclusions:
An unfavorable social profile is an independent risk factor for mortality in patients with advanced HF.
More Related Videos
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
03:47Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Diuretics
Heart Failure V: Medical Management